RecruitingPhase 4NCT05585983

INfluenza VaccInation To Mitigate typE 1 Diabetes

INfluenza VaccInation To Mitigate typE 1 Diabetes (INVITED Trial)


Sponsor

Aarhus University Hospital

Enrollment

100 participants

Start Date

Dec 14, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

In a multicenter, prospective, randomized, controlled clinical trial to compare influenza vaccination and placebo in sustaining β cell function in early type 1 diabetes mellitus.


Eligibility

Min Age: 7 YearsMax Age: 17 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether giving an influenza (flu) vaccine to children newly diagnosed with type 1 diabetes helps preserve some of their remaining insulin-producing cells. The idea is that the flu vaccine may reduce immune activation that attacks the pancreas right after diagnosis. **You may be eligible if...** - You are a child (or parent/guardian) hospitalized with a new diagnosis of type 1 diabetes - Informed consent can be provided by a parent or legal guardian **You may NOT be eligible if...** - The child already received a flu vaccine this season - There is a strong medical reason to get the flu vaccine unrelated to diabetes - There is a severe egg allergy or previous allergic reaction to the flu vaccine - The child currently has a fever or active infection - The child has a condition causing immune suppression that may reduce vaccine effectiveness - A parent or guardian is unable to provide consent Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BIOLOGICALVaxigrip Tetra Sanofi Pasteur Europe

We will use 0.5 mL standard dose quadrivalent influenza vaccine containing 15 μg of hemagglutinin per strain consistent with WHO recommendations according to season.


Locations(10)

Aalborg University Hospital

Aalborg, Denmark

Aarhus University Hospital

Aarhus, Denmark

Steno Diabetes Center Copenhagen

Copenhagen, Denmark

Gødstrup Hospital

Herning, Denmark

Holbaek Sygehus

Holbæk, Denmark

Nykoebing F Sygehus

Nykøbing Falster, Denmark

Randers Regional Hospital

Randers, Denmark

Sjællands Universitetssygehus

Roskilde, Denmark

Slagelse Hospital

Slagelse, Denmark

Viborg Regional Hospital

Viborg, Denmark

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05585983


Related Trials